Switch to:
More From Other Websites
OCULAR THERAPEUTIX, INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of... Jun 23 2016
7 Biopharma Companies That Destroyed Shareholders Last Week Jun 12 2016
This stock’s crash is a cautionary tale on the dangers of betting on biotech IPOs Jun 07 2016
Chesapeake Energy, Devon and Ciber climb, AbbVie slips Jun 06 2016
Why Ocular Therapeutix (OCUL) Stock Is Tanking Today Jun 06 2016
Why Adamis Pharmaceuticals, Immunomedics and Three Other Stocks Are Deep in Red Today? Jun 06 2016
The 5 Biggest Biotech and Pharma Losers From ASCO Jun 06 2016
Stocks to Watch: Adamis Pharmaceuticals, Ocular Therapeutix, ProNAi Therapeutics Jun 06 2016
Why Ocular Therapeutix Is Sinking Despite Mixed Results Jun 06 2016
Ocular Therapeutix Inc Conference Call to Discuss the Results of Phase 3 Clinical Trial for... Jun 06 2016
Stock Futures Inch Higher as Wall Street Awaits Yellen Jun 06 2016
Ocular Therapeutix's late-stage trial of pink eye treatments fails to meet objective Jun 06 2016
OCULAR THERAPEUTIX, INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Jun 06 2016
Ocular Therapeutix™ Announces Topline Results of Second Phase 3 Clinical Trial of DEXTENZA™ for... Jun 06 2016
Ocular Therapeutix™ to Present at Two Upcoming Investor Conferences Jun 02 2016
OCULAR THERAPEUTIX, INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Jun 02 2016
Ocular Therapeutix™ to Present at Two Upcoming Investor Conferences Jun 02 2016
OCULAR THERAPEUTIX, INC Financials May 19 2016
Edited Transcript of OCUL earnings conference call or presentation 10-May-16 12:00pm GMT May 10 2016
Ocular Therapeutix Inc Earnings Call scheduled for 8:00 am ET today May 10 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK